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ABSTRACT 
Staphylococci are one of the foremost causes of urinary tract infections (UTIs) in humans. The emergence of 
multiple drug resistance (MDR) among Staphylococci poses serious challenges in antimicrobial therapy for 
UTIs. Most work has been done on S. aureus while coagulase negative Staphylococci (mainly S. epidermidis) are 
often neglected. This study was conducted to establish a baseline profile of drug resistance in local S. epidermid-
is isolates from UTIs. Eighty urine samples were collected from suspected UTIs cases and screened for S. epi-
dermidis. Twenty isolates were suspected as S. epidermidis based on colony morphology and Gram staining. 
Molecular detection by polymerase chain reaction (PCR) confirmed 13 isolates as S. epidermidis. Using disc dif-
fusion method, phenotypic drug resistance of the isolates was observed towards erythromycin (100 %), gen-
tamycin, azithromycin and tetracycline (92.3 %), ampicillin and oxytetracyclin (84.6 %), amikacin and srtepto-
mycin (76.9 %), methicillin (69.2 %), cephradine, cefaclor and cefazolin (53.8 %) and vancomycin (15.3 %). 
Eighteen most commonly reported genes responsible for conferring resistance towards these drugs were targeted 
by PCR: among these tetM gene was found most prevalent (46.1 %) followed by tetK (30.7 %), aac(6’)/aph(2”) 
(30.7 %), aacA-aphD (23 %), ermA (23 %), blaZ (23 %), mecA (23 %) blaTEM-1 (23 %), MeccA (23 %) and 
mecA (15.3 %). No gene fragment for vancomycin resistance was detected. The salient finding was that all S. ep-
idermidis isolates were multiple drugs resistant as they showed resistance against at least three structurally dif-
ferent antimicrobial agents. It is concluded that in addition to the mostly used antimicrobial agent vancomycin, 
the cephalosporins including cephradine, cefaclor and cefazolin are also the drugs of choice against UTIs caused 
by S. epidermidis. 
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INTRODUCTION 
Urinary tract infections (UTIs) caused by 
pathogenic bacteria are considered as the 
second common category of infections in the 
body and around 8.1 million visits to health 
care are reported each year (Griebling, 
2004). The UTIs are often asymptomatic, 
although occasionally they produce distress 
in kidney transplant recipients, patients with 
an invasive genitourinary procedure, in 
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pregnant women and in neutropenic patients 
(Gleckman, 1992). Symptomatic UTIs can 
be either uncomplicated involving only uri-
nary bladder or complicated leading to pye-
lonephritis or other metabolic and anatomi-
cal disorders. In patients with symptomatic 
infections presence of inflammatory cells 
and > 105 bacteria per ml in freshly voided 
urine are reported (Lee and Neild, 2007). 
There are several factors that affect the clini-
cal manifestation of UTIs e.g. it depends on 
the severity of the infection, part of the uri-
nary tract affected, the etiologic organism 
and patient’s ability to mount strong immune 
response. Common symptoms are fever, uri-
nary urgency, chills, dysuria and cloudy 
urine (Mori et al., 2007). UTIs in children 
are more severe because they are more likely 
to damage the kidneys. Among children, 
poor urine control and bedwetting during the 
day are common signs (Lee and Neild, 
2007). 
The risk of UTIs is more in females; one 
reason is the shorter urethra in women that 
allows bacteria quicker access to reach the 
bladder (Farshad et al., 2010). Recurrent 
UTIs are common clinical problems and 
about 25 % of women with an acute UTI suf-
fer a recurrence in 6 months, even when they 
are receiving a proper antibiotic therapy 
(Schilling et al., 2002). Significant rates of 
morbidity and even mortality are observed in 
many cases of UTIs. It increases the risk of 
fetal mortality especially in weak elderly 
persons, pregnant women and pediatric pa-
tients (Martineau et al., 2000). Urosepsis 
leading to death is also reported. Epidemiol-
ogy of UTIs varies with several factors like 
gender, age, and the existence of genitouri-
nary disorders (Griebling, 2004). 
Bacteria are considered as the most 
common cause of lower and upper urinary 
tract infections. Among bacterial infections, 
Escherichia coli is reported as the most 
common bacterium and it accounts for about 
85 % of community-acquired and 50 % of 
hospital acquired urinary tract infections fol-
lowed by Staphylococcus species that con-
tribute up to 15 % (Vasudevan, 2014). 
Staphylococcus epidermidis is a coagu-
lase negative Staphylococci and one of the 
most often reported Staphylococcus in noso-
comial infections. It usually enters the uri-
nary tract through urethra and resides on the 
skin or mucous membrane (Golding et al., 
2012). Recently, the S. epidermidis isolated 
from the hospital environment (catheter-
related bloodstream infections and healthcare 
workers) was found resistant to more antibi-
otics than S. epidermidis colonizing healthy 
volunteers. It clearly suggests the S. epider-
midis as potential cause of catheter related 
infections due to its antimicrobial resistance 
based adaptability to survive in the hospital 
environment (Cherifi et al., 2014). To the 
best of our knowledge, there is no report ear-
lier on molecular detection of antimicrobial 
resistance is S. epidermidis from this region. 
 
MATERIALS AND METHODS 
Sample collection and bacterial isolation 
Urine samples (no = 80) were aseptically 
collected from patients of all age groups and 
both sexes. The samples were collected from 
different laboratories and hospitals (Millat 
laboratory, PINUM hospital, Nusrat labora-
tory, Allied Hospital) of Faisalabad. Sterile 
leak resistant containers were used for col-
lection and transportation of urine from hos-
pitals to our laboratory and inoculated into 
0.6 % nutrient agar in tryptic soya broth. The 
well-mixed unspun urine was streaked on 
nutrient ager plates using sterile swab and 
incubated overnight at 37 °C. The agar plates 
were observed for the presence of Staphylo-
coccus colonies. The suspected isolates were 
sub-cultured on the same medium for obtain-
ing pure cultures and processed for biochem-
ical and molecular identification. 
 
Biochemical identification of isolates 
The isolates suspected as Staphylococcus 
were processed for Gram-staining and ob-
served under light microscope (Buck, 1982). 
The coagulase test was performed (Skinner 
et al., 2009) on glass slides to detect coagu-
lase negative Staphylococci. Briefly, the iso-
lates were cultured on nutrient agar plates 
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and a suspension of colonies was made with 
saline. Two drops of the suspension were 
mixed with same volume of human blood 
plasma by sterilized plastic tip and the re-
sults regarding clumping or otherwise were 
noted within 10 seconds while gently rotat-
ing the glass slide in circular manner. 
 
Molecular identification of Staphylococcus 
epidermidis 
Total genomic DNA from all isolates 
suspected as Staphylococci was extracted 
from the overnight culture at 37 °C in tryptic 
soy broth (TSB) using the phenol-
chloroform method (Sambrook et al., 1989). 
The integrity of DNA samples was checked 
by electrophoresis on 1 % agarose gel. Pol-
ymerase chain reaction (PCR) was per-
formed for the confirmation of S. epidermid-
is isolates with SE-F and SE-R primers 
(Martineau et al., 2000) targeting 124 base 
pairs S. epidermidis specific gene fragment. 
The 25 µL PCR reaction mixture including 5 
µL of diluted template DNA was made up of 
2.5 µL of 10X PCR buffer, 1.6 µL of 25mM 
MgCl2, 1.6 µL of dNTPs, 1.5 µL of each 
primer and 0.3 µL of Taq polymerase. The 
thermal cycler conditions were 95 °C for 3 
min (initial denaturation), followed by 35 
cycles of 95 °C for 1 min, 60 °C for 40 sec, 
72 °C for 50 sec and a final extension of 
72 °C for 7 min. 
 
Antimicrobial susceptibility testing 
After PCR confirmation of the isolates, 
antimicrobial susceptibility testing was per-
formed by disc diffusion method against six 
different antimicrobial groups, using discs of 
thirteen representative antimicrobials: ami-
kacin (30 μg), ampicillin (10 μg), cefradine 
(30 μg), cefaclor (30 μg), cefazolin (30 μg), 
gentamicin (10 μg), streptomycin (10 μg), 
vancomycin (30 μg), azithromycin (15 μg), 
erythromycin (15 μg), methicillin (10 μg), 
tetracycline (30 μg) and oxytetracycline (30 
μg). The diameter of zone of inhibition, if 
present was measured and results for all an-
timicrobials used were interpreted according 
to the guidelines of Clinical And Laboratory 
Standard Institute (CLSI, 2012). 
 
Molecular detection of antimicrobial drug 
resistance genes 
PCR was used to amplify 18 most com-
monly targeted drug resistance gene frag-
ments in all S. epidermidis isolates as de-
scribed by previous studies. For aminoglyco-
sides (amikacin, gentamicin, streptomycin) 
the resistance genes (aac(6’)/aph(2”) 
(Kozitskaya et al., 2004) and aacA-aphD 
(Strommenger et al., 2003) were targeted 
while blaTEM-1 resistance gene fragment was 
targeted (Yan et al., 2000) for cephalosporins 
(cefaclor, cefazolin and cephradine). For 
macrolides (erythromycin and azithromycin) 
the ermA and ermC resistance gene frag-
ments were targeted (Strommenger et al., 
2003). For tetracyclines (tetracycline and 
oxytetracycline) the tetM and tetK gene 
fragments were targeted (Strommenger et al., 
2003). For beta-lactams (ampicillin and 
methicillin), the targeted gene fragments 
were blaZ (EI Zubeir et al., 2007), mecA (EI 
Zubeir et al., 2007), meccA (Del Vecchio et 
al., 1995), and MeccA (Vannuffel et al., 
1995). Seven different resistance gene frag-
ments including vanR, vanS, vanH, vanA, 
vanX, vanY and vanZ were targeted (Dezfu-
lian et al., 2012) for detection of vancomycin 
(glycopeptides) resistance genes. The se-
quences of primers along with sizes of am-
plicons are mentioned in Table 1. 
 
RESULTS 
Out of 80 collected samples, 20 were 
suspected as Staphylococci based on colony 
morphology and Gram staining (positive). 
All these isolates were found coagulase neg-
ative as no clumping of human plasma was 
observed with them while the positive con-
trol Staphylococcus aureus showed clear 
clumping (Figure 1). The PCR confirmed 13 
isolates as S. epidermidis as amplified prod-
uct of 124 base pairs was observed in each 
case with no amplification in negative con-
trol. 
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Table 1: Drug resistance primers used in the study 
Gene Primers Sequences Amplicon size (bp) Reference 
blaTEM-1 
blt-F CCCCTATTTGTTTATTTTTC 
962 (Yan et al., 2000) 
blt-R GACAGTTACCAATGCTTAAT 
blaZ 
BlaZ-F ACTTCAACACCTGCTGCTTTC 
173 (EI Zubeir et al., 2007) BlaZ-R TGACCACTTTTATCAGCAACC 
mecA 
MecA-F AAAATCGATGGTAAAGGTTGGC 
532 (EI Zubeir et al., 2007) MecA-R AGTTCTGCAGTACCGGATTTGC 
aac(6’)/ 
aph(2”) 
aaC-F GTATTAGAATTTTATGGTGG 
1184 (Kozitskaya et al., 2004) aaC-R CCATACATTCTTAATATATC 
MeccA 
M-F TGGCTATCGTGTCACAATCG 
310 (Vannuffel et al., 1995) M-R CTGGAACTTGTTGAGCAGAG 
meccA 
MRS-F TAGAAATGACTGAACGTCCG 
154 (Del Vecchio et al., 1995) MRS-R TTGCGATCA ATGTTACCGTAG 
aacA-
aphD 
aacA-D-F TAATCCAAGAGCAATAAGGGC 
227 (Strommenger et al., 2003) aacA-D-R GCCACACTATCATAACCACTA 
erm(A) 
ErmA-F AAGCGGTAAACCCCTCTGA 
190 (Strommenger et al., 2003) ErmA-R TTCGCAAATCCCTTCTCAAC 
erm(C) 
ErmC-F AATCGTCAATTCCTGCATGT 
299 (Strommenger et al., 2003) ErmC-R TAATCGTGGAATACGGGTTTG 
tetK 
TetK-F GTAGCGACAATAGGTAATAGT 
360 (Strommenger et al., 2003) TetK-R GTAGTGACAATAAACCTCCTA 
tetM 
TetM-F AGTGGAGCGATTACAGAA 
158 (Strommenger et al., 2003) TetM-R CATATGTCCTGGCGTGTCTA 
vanR 
VanR-F AGCGATAAAATACTTATTGTGGA 
645 (Miele et al., 1995) VanR-R CGGATTATCAATGGTGTCGTT 
vanS 
Vans-F TTGGTTATAAAATTGAAAAATAA 
1155 (Whitener et al., 2004) Vans-R TTAGGACCTCCTTTTATC 
vanH 
VanH-F ATCGGCATTACTGTTTATGGAT 
943 (Miele et al., 1995) VanH-R TCCTTTCAAAATCCAAACAGTTT 
vanA 
VanA-F ATGAATAGAATAAAAGTTGCAATAC 
1029 (Miele et al., 1995) VanA-R CCCCTTTAACGCTAATACGAT 
vanX 
VanX-F ATGGAAATAGGATTTACTTT 
609 (Whitener et al., 2004) VanX-R TTATTTAACGGGGAAATC 
vanY 
VanY-F ATGAAGAAGTTGTTTTTTTTA 
912 (Whitener et al., 2004) VanY-R TTACCTCCTTGAATTAGTAT 
vanZ 
VanZ-F TTATCTAGAGGATTGCTAGC 
454 (Woodford, 1998) 
VanZ-R AATGGGTACGGTAAACGAGC 
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The results of antimicrobial sensitivity 
testing by disc diffusion method for the 13 S. 
epidermidis isolates showed that all isolates 
have phenotypic resistance to at least three 
antimicrobial drugs (belonging to three dif-
ferent groups) so all the isolates were con-
sidered as multiple drug resistant (MDR) iso-
lates (Zhao et al., 2005). With disc diffusion 
method, all 13 (100 %) isolates showed re-
sistance to erythromycin, whereas 12 
(92.3 %) were resistant to gentamycin, 
azithromycin, and tetracycline. Eleven iso-
lates (84.6 %) were resistant to ampicillin 
and oxytetracyclin, 10 (76.9 %) were found 
resistant to amikacin and streptomycin, 9 
isolates (69.2 %) were resistant to methicillin 
and only 7 isolates (53.8 %) were resistant to 
cephradine, cefaclor and cefazolin while on-
ly two isolates (15.3 %) were found pheno-
typically resistant to vancomycin (Figure 2) 
but no gene for vancomycin resistance was 
detected. 
The PCR based detection of different an-
timicrobial resistance genes showed the 
presence of aacA-aphD gene in 3 isolates 
(23 %), erm(A) gene fragment in 3 isolates 
(23 %), tetK gene fragment (360 bp) in 4 iso-
lates (30.7 %) and tetM in 6 (46.1 %) iso-
lates. The blaZ gene which confers re-
sistance to penicillin was detected in 3 iso-
lates (23 %). No amplification was observed 
with primer sets used for genes reported to 
confer resistance against vancomycin. In the 
duplex PCR for MeccA and mecA, responsi-
ble for conferring resistance to methicillin, 
the MeccA was amplified in 3 isolates (23 %) 
and mecA was amplified in 2 isolates 
(15.3 %) while in 3 phenotypically resistant 
isolates, no gene was detected for methicillin 
resistance. The gene fragment of bla TEM-1 
was amplified (962 bp) in 3 isolates (23 %) 
while the gene aac(6’)/aph(2”) responsible 
to confer resistance to gentamicin was found 
(1184 bp) in 4 isolates (30.7 %). The repre-
sentative amplified products are shown in 
Figure 3.  
 
Figure 1: Coagulase test for Staphylococci. Con-
trol test (left) showing clumping when Staphylo-
coccus aureus suspension reacted with human 
plasma while the reaction test (right) with coagu-
lase negative Staphylococci showing no clump-
ing 
 
 
Figure 2: Antimicrobial drug resistance Staphy-
lococci on Muller Hinton agar plates. A: Bacteria 
showing intermediate resistance against the an-
timicrobial. B: Bacteria showing complete sus-
ceptibility against the antimicrobial as indicative 
by the clear zone of inhibition. C: Bacteria show-
ing resistance as no zone of inhibition. 
 
 
Figure 3: Amplification of drug resistance genes. 
Lanes1 and 8: Amplified product of 360 bp of 
tetK gene fragment. Lanes 2, 5 and 7: Amplified 
product of 190 bp of erm(A). Lane 6: 100 bp 
GeneRuler (invitrogen). 
 1     2    3    4    5    6     7    8 
360 bp 
190 bp 
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DISCUSSION 
The urinary tract of humans is a multi-
organ system comprises of kidneys, bladder, 
urethra and ureters. Urinary tract infections 
(UTIs) are usually caused by pathogenic mi-
croorganisms (viruses, bacteria, fungi or par-
asites). These are considered the second 
common category of infections in the body 
(Griebling, 2004). The urosepsis, pyelone-
phritis, metabolic and anatomical disorders 
are observed in complicated infections of the 
urinary tract that lead to tissue injury. It usu-
ally enters in the urinary tract through ure-
thra and resides on the skin or mucous mem-
brane (Golding et al., 2012). There are dif-
ferent groups of antimicrobial drugs that act 
on bacteria including S. epidermidis in dif-
ferent ways, as each antimicrobial drug has a 
specific mode of action (Neu, 1992).  
Beta-lactam drugs including penicillins, 
ampicillins and oxacillins are considered to 
be a major group of antimicrobial drugs. Re-
sistance to penicillins is mostly caused by 
the presence of ß-lactamases, but mutations 
in penicillin binding proteins (PBPs) of bac-
teria also have resulted in reduced affinity 
for ß-lactams (Brinas et al., 2005). Methicil-
lin and amplicillin are used as representa-
tives of this group. Methicillin resistance in 
Staphylococci has been reported to be asso-
ciated with the presence of PBPs encoded by 
the MeccA gene (Zapun et al., 2008; Choi et 
al., 2003). The high level of resistance was 
found against methicillin (69.2 %) in our iso-
lates using disk diffusion method but the 
genes involved in conferring resistance to 
methicillin (MeccA and mecA), were identi-
fied in three and two isolates respectively. 
The possible reason for this difference in 
genotypic and phenotypic antimicrobial sen-
sitivity patterns is the presence of other drug 
resistance genes which were not included in 
this study. Results about resistance to methi-
cillin found in this study were higher than 
those reported (34.2 %) from Turkey (Hos-
gor et al., 2007) and Europe (25 %) (Fluit et 
al., 2001) but were comparable to those re-
ported from USA (Marshall et al., 1998). 
The resistance against gentamicin was 
found in 12 (92.3 %) isolates in our study by 
disc diffusion method. The presence of ami-
noglycoside-modifying enzyme (AME) 
genes aac(6’)/aph(2”) and aacA-aphD gene 
fragments was also checked. The gene 
aac(6’)/aph(2”) responsible to confer re-
sistance against gentamicin was amplified 
(1184 bp) in 4 isolates (30.7 %) and aacA-
aphD was amplified (227 bp) in 3 isolate (23 
%). In accordance with previous studies 
(Vanhoof et al., 1994; Choi et al., 2003), we 
also found the aac(6’)/aph(2’’) gene as the 
most prevalent AME gene in Staphylococci. 
Contrarily, a study from Japan reported less 
frequent detection of aac(6’)/aph(2’’) gene 
among clinical MRSA isolates (Ida et al., 
2001). 
In case of erythromycin, all (13) isolates 
were found phenotypically resistant while 
PCR assay detection erm(A) gene fragment 
in only 3 isolates (23 %) while no amplifica-
tion was observed for erm(C) gene fragment. 
Previously, the erm(A)gene was reported as 
more prevalent than the other erythromycin 
resistance genes in S. aureus while erm(C) 
gene is present more frequently in coagulase 
negative Staphylococci (Lim et al., 2002). 
Erythromycin resistant might be due to the 
presence of msrA or ermB gene fragments as 
previously described (Weisblum, 1995) 
which were not included in our study. The 
resistance against tetracycline and oxytetra-
cyclin was phenotypically observed in 12 
(92.3 %) and 11 (84.6 %) isolates respective-
ly. Tetracycline resistance gene fragments 
tetK and tetM were targeted in this study and 
tetK was amplified in 3 (23 %) isolates while 
tetM gene fragment was amplified in 6 
(46.1 %) isolates. However, we found nei-
ther of these genes in 4 (30.7 %) phenotypi-
cally resistant isolates which indicates the 
possibility of carrying some other tetracy-
cline resistance genes (Roberts, 2005) or 
harboring some other antimicrobial re-
sistance phenomenon (Guardabassi et al., 
2000). 
In this study, we found 2 (15.3 %) iso-
lates resistant to vancomycin (phenotypical-
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ly) by disc diffusion method but not a single 
isolate showed amplification in the multiplex 
PCR for the targeted seven gene fragments 
i.e. vanR, vanS, vanH, vanA, vanX, vanYand 
vanZ. One possible reason is that the most 
effective form of vancomycin resistance de-
pends on a transposon containing seven 
genes, the products of which work together 
to sense the presence of vancomycin, shut 
down the normal pathway for bacterial cell 
wall synthesis, and generate a different type 
of cell wall. Therefore, the joining of these 
genes into a single transposon must have 
been a difficult evolutionary step. Moreover 
the bacteria may have some other alternative 
strategies to confer resistance against van-
comycin. There are only a few cases reported 
all over the world about isolation of vanco-
mycin resistant S. aureus (VRSA) from clin-
ical specimens and among these isolates 
small number was community-acquired. The 
first case of community-acquired methicillin 
and vancomycin-resistant S. aureus was re-
ported in Tehran, Iran. According to it in-
vitro transfer of vancomycin resistance gene 
(vanA) from the source Enterococci to S. au-
reus isolates, it was suspected that there is a 
possibility of transformation of vanA gene 
from vancomycin resistant Enterococci 
(VRE) to Staphylococci species (Whitener et 
al., 2004). 
Increased resistance in bacteria particu-
larly in methicillin resistant S. aureus 
(MRSA) to several antimicrobial agents has 
aggravated due to the over use of vancomy-
cin as a first-line empirical therapy as well as 
in prophylaxis therapy, though the selection 
of vancomycin resistance and the potential 
transmission of resistance in species encour-
age restricted use of these glycopeptides 
(Maccanti and Bonadio, 1992; Grayson, 
1993). 
Another major group of antimicrobial 
drugs is cephalosporins. These drugs are 
very efficient and several generations are 
available in the market. First generation 
preparations (cefaclor, cefadroxil, cephaz-
olin, cefradine, cephalexin, cephaloridine 
etc.) are generally active against gram-
positive bacteria. We used three drugs i.e. 
cephazolin, cefradine and cefaclor. With disc 
diffusion method, 7 (53.8 %) isolates were 
observed to be resistant against these antimi-
crobials. While in a multiplex PCR assay bla 
TEM-1 gene involved in conferring re-
sistance to cephalosporins was found in only 
3 isolates (23 %). We conclude that vanco-
mycin is the drug of choice against UTIs 
caused by Staphylococci and cephalosporins 
including cephradine, cefaclor and cefazolin 
are also still effective in this geographic re-
gion. 
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